Researchers at the US National Institute for Allergies and InfectiousDiseases (NIAID) have claimed that Moderna’s COVID-19 vaccine, mRNA-1273,produces potent antibodies that last over three months.

NIAID researchers have made this claim after studying the immune responseof 34 adults who had participated in the phase-I of clinical trials ofModerna’s vaccine. All participants were administered two shots of thevaccine 28 days apart.——————————

According to the NIAID study, which was published recently in the NewEngland Journal of Medicine, the antibodies, which prevent the SARS-CoV-2virus from invading human cells, declined slightly over time, as expected,but they remained elevated in all participants 3 months after beingvaccinated.

Although the antibodies diminish over time, it is not a cause of concern asthe vaccine also activated a special type of immune cell that helped theimmune system retain information of the SARS-COV-2 in the immunologicalmemory, the study adds.

Director NIAID, Anthony Fauci, has said that chances are high that theModerna’s vaccine will allow the immune system to remember the Coronavirusfor a long time and will reproduce antibodies against it on exposure in thefuture.